on Champions Oncology, Inc. (NASDAQ:CSBR)
Champions Oncology Expands Bioanalytical Services with New Technology
Champions Oncology, Inc., a prominent oncology research organization, has announced enhancements to its bioanalytical services. The company has integrated Cytek Aurora flow cytometers into its offerings, boosting its capabilities in spectral and conventional flow cytometry. This development aims to deepen service complexity and competitiveness in the market.
The company also appointed Troy Tremaine to lead its bioanalytical commercial strategy. With extensive experience in the field, Tremaine is expected to drive growth in this business area. CEO Ronnie Morris expressed enthusiasm about these strategic investments and the potential benefits they bring to the company's growth trajectory.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Champions Oncology, Inc. news